1. Amyotrophic lateral sclerosis: Part 2. etiopathogenesis;R, I.Tanden; WG, Bradley;Ann Neurol,1985
2. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone;Engel, W.K.; Sidique, T.; Nicoloff, J.T.;Lancet,1983
3. Reduced lumbar cerebrospinal fluid corticotropin releasing factor levels in amyotrophic lateral sclerosis;Klimek, A.; Cieslak, D.; Szulc-Kuberska, J.; Stepiefi, H.;Acta Neurol Scand,1986
4. Amyotrophic lateral sclerosis. A study of central metabolism and therapeutic trial of levodopa;Mendell, JR, Chase; TN, Engel; W.K.;Arch Neurol,1971
5. Neurol Control of prolactin secretion in man;Boyd, A.E.; Reichlin, S.;Psychoneuroendocrinology,1978